In this two-sample MR analysis with the largest GWAS datasets, we systematically screened 41 cytokines and identified that genetically predicted circulating levels (1-SD increase) of MCP1, MIP1b, and IL13 were all significantly associated with increased risk of overall BC and ER-positive BC. The gene discussed is CCL2; the disease is breast cancer.